FINA, MARIAPAOLA
FINA, MARIAPAOLA
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
2012 Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M.
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.
2010 Zinzani PL; Venturini F; Stefoni V; Fina M; Pellegrini C; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M.
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients.
2010 Zinzani P.L.; Rossi G.; Franceschetti S.; Botto B.; Di Rocco A.; Cabras M.G.; Petti M.C.; Stefoni V.; Broccoli A.; Fanti S.; Pellegrini C.; Montini G.C.; Gandolfi L.; Derenzini E.; Argnani L.; Fina M.; Tucci A.; Bottelli C.; Pileri S.; Baccarani M.
Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome.
2010 Zinzani P.L.; Gandolfi L.; Stefoni V.; Fanti S.; Fina M.; Pellegrini C.; Montini G.C.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M.
CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission.
2009 Stefoni V; Broccoli A; Pellegrini C; Derenzini E; Fina M; Zinzani PL.
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma
2009 Zinzani P.L.; Stefoni V.; Tani M.; Fanti S.; Musuraca G.; Castellucci P.; Marchi E.; Fina M.; Ambrosini V.; Pellegrini C.; Alinari L.; Derenzini E.; Montini G.; Broccoli A.; Bacci F.; Pileri S.; Baccarani M.
A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma
2008 Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenzini E.; Baccarani M.
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.
2007 Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpiaz G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M.
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.
2006 Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; Fina M.; Farshad M.; Pileri S.; Baccarani M.
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma.
2005 Tani M; Fina M; Alinari L; Stefoni V; Baccarani M; Zinzani PL.
Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma.
2005 ZINZANI PL; ALINARI L; TANI M; FINA M; PILERI S; BACCARANI M.
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy.
2005 Zinzani PL; Tani M; Alinari L;Molinari AL;Stefoni V.;Visani G.; Gentilini P.; Guardigni L.; Fina M.; Baccarani M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; P...ellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. | 2012-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. |
Zinzani PL; Venturini F; Stefoni V; Fina M; Pellegrini C; Derenzini E; Gandolfi L; Broccoli A; A...rgnani L; Quirini F; Pileri S; Baccarani M. |
2010-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients. | Zinzani P.L.; Rossi G.; Franceschetti S.; Botto B.; Di Rocco A.; Cabras M.G.; Petti M.C.; Stefoni... V.; Broccoli A.; Fanti S.; Pellegrini C.; Montini G.C.; Gandolfi L.; Derenzini E.; Argnani L.; Fina M.; Tucci A.; Bottelli C.; Pileri S.; Baccarani M. | 2010-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome. | Zinzani P.L.; Gandolfi L.; Stefoni V.; Fanti S.; Fina M.; Pellegrini C.; Montini G.C.; Derenzini ...E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M. | 2010-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission. | Stefoni V; Broccoli A; Pellegrini C; Derenzini E; Fina M; Zinzani PL. | 2009-01-01 | JOURNAL OF NEURO-ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma | Zinzani P.L.; Stefoni V.; Tani M.; Fanti S.; Musuraca G.; Castellucci P.; Marchi E.; Fina M.; Amb...rosini V.; Pellegrini C.; Alinari L.; Derenzini E.; Montini G.; Broccoli A.; Bacci F.; Pileri S.; Baccarani M. | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma | Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenz...ini E.; Baccarani M. | 2008-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. | Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpia...z G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M. | 2007-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. | Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; F...ina M.; Farshad M.; Pileri S.; Baccarani M. | 2006-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma. | Tani M; Fina M; Alinari L; Stefoni V; Baccarani M; Zinzani PL. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma. | ZINZANI PL; ALINARI L; TANI M; FINA M; PILERI S; BACCARANI M. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy. | Zinzani PL; Tani M; Alinari L;Molinari AL;Stefoni V.;Visani G.; Gentilini P.; Guardigni L.; Fina ...M.; Baccarani M. | 2005-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |